Skip to main content
Premium Trial:

Request an Annual Quote

BD Acquires Cell Sorting Instrument Firm

NEW YORK (GenomeWeb News) – Becton Dickinson said last night that it has acquired all of the outstanding stock of privately held Cytopeia, which makes advanced flow cytometry cell sorting instruments.
BD did not disclose financial terms of the acquisition but said that is not expected to have a material impact on the firm’s 2008 earnings.
Franklin Lakes, NJ-based BD said that Cytopeia’s Influx cell sorter provides the firm with an open, configurable cell sorting platform that can be fully optimized for application-specific requirements. It said the Influx could be used in cell therapy research, stem cell research, drug discovery and development, and marine biology applications and is complementary to its FACSAria II system.
Seattle-based Cytopeia was the first spin-off from the Institute for Systems Biology.
Cytopeia President and Chief Technology Officer Ger van den Engh will join BD Biosciences as VP of Advanced Cytometry and continue research and technology development activities in Seattle, said BD.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.